Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.

Medtronic’s diabetes division seeks $7.9B valuation in upcoming IPO
MiniMed, Medtronic's diabetes business, hopes to sell 28 million shares of its common stock at a price of $25 to $28 per share.
New study of homozygous familial hypercholesterolemia finds higher LDL-C levels in women
The American Society for Preventive Cardiology celebrated researchers for uncovering new insights into this rare condition.
Statin labeling should be revised with updated warnings, meta-analysis confirms
Researchers explored data from more than 123,000 patients, noting that dozens of the adverse complications included on current labels can safely be removed.
Esperion settles another lawsuit to keep generic versions of popular drug off shelves
As soon as Esperion Therapeutics gained FDA clearance for Nexletol in 2020, competitors started trying to copy it. The company is fighting back.
Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks
Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

Medtronic’s diabetes division seeks $7.9B valuation in upcoming IPO

MiniMed, Medtronic's diabetes business, hopes to sell 28 million shares of its common stock at a price of $25 to $28 per share.

New study of homozygous familial hypercholesterolemia finds higher LDL-C levels in women

The American Society for Preventive Cardiology celebrated researchers for uncovering new insights into this rare condition.

Statin labeling should be revised with updated warnings, meta-analysis confirms

Researchers explored data from more than 123,000 patients, noting that dozens of the adverse complications included on current labels can safely be removed.

Esperion Therapeutics Inc. has filed patent infringement lawsuits against eight generic drug makers for filing U.S. Food and Drug Administration (FDA) abbreviated new drug applications (ANDA) to make generic versions of its successful bempedoic acid (Nexletol).

Esperion settles another lawsuit to keep generic versions of popular drug off shelves

As soon as Esperion Therapeutics gained FDA clearance for Nexletol in 2020, competitors started trying to copy it. The company is fighting back.

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

Blood glucose monitor instructions updated due to error code linked to 114 injuries

No devices need to be returned or replaced, but the company did want to update their instructions for use.

Cardiologist impressed by experimental pill that significantly lowers cholesterol

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care.

New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease

New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.